These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 28976989

  • 1. Vitamin D and methylarginines in chronic kidney disease (CKD).
    Torino C, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.
    PLoS One; 2017; 12(10):e0185449. PubMed ID: 28976989
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.
    Spoto B, Pizzini P, Cutrupi S, Tripepi G, Curatola G, Mallamaci F, Zoccali C.
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):291-297. PubMed ID: 29307660
    [Abstract] [Full Text] [Related]

  • 3. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.
    MacAllister RJ, Rambausek MH, Vallance P, Williams D, Hoffmann KH, Ritz E.
    Nephrol Dial Transplant; 1996 Dec; 11(12):2449-52. PubMed ID: 9017621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW, Kiefte-de Jong JC, ter Wee PM, Stehouwer CD, van Ittersum FJ, Olthof MR, Teerlink T, Twisk JW, van Guldener C, Smulders YM.
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [Abstract] [Full Text] [Related]

  • 6. FGF23 and the PTH response to paricalcitol in chronic kidney disease.
    D'Arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.
    Eur J Clin Invest; 2020 Feb; 50(2):e13196. PubMed ID: 31863599
    [Abstract] [Full Text] [Related]

  • 7. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry.
    Wang S, Vicente FB, Miller A, Brooks ER, Price HE, Smith FA.
    Clin Chem Lab Med; 2007 Feb; 45(10):1305-12. PubMed ID: 17663630
    [Abstract] [Full Text] [Related]

  • 12. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C.
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [Abstract] [Full Text] [Related]

  • 13. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients.
    Coen G, Mantella D, Sardella D, Beraldi MP, Ferrari I, Pierantozzi A, Lippi B, Di Giulio S.
    J Nephrol; 2009 Dec; 22(5):616-22. PubMed ID: 19809994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Dec; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
    Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD.
    JAMA; 2012 Feb 15; 307(7):674-84. PubMed ID: 22337679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.